A placebo-controlled, double-blind trial of infliximab for cancer-associated weight loss in elderly and/or poor performance non-small cell lung cancer patients (N01C9) - Jatoi, A; Ritter, H L; Dueck, A (Lung Cancer, 2010)
, et al.